Page 1 of 9 Title: Flow Cytometric Testing for Kappa and Lambda light chains Sponsored and reviewed by ICCS Quality and Standar
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
trend in serum free light chain levels and kappa-lambda free light... | Download Scientific Diagram
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
Life | Free Full-Text | Relapse of Monoclonal Gammopathy of Renal Significance after mRNA COVID-19 Vaccination: A Case Report
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination | Nature Medicine
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Familial Myeloma | NEJM
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study - The Lancet Regional Health – Americas
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect
Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Vaccines | Free Full-Text | Immune Control of Avian Influenza Virus Infection and Its Vaccine Development
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
